Wu-Ping Zheng

485 total citations
27 papers, 349 citations indexed

About

Wu-Ping Zheng is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wu-Ping Zheng has authored 27 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wu-Ping Zheng's work include Cancer Immunotherapy and Biomarkers (4 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Wu-Ping Zheng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Wu-Ping Zheng collaborates with scholars based in China, Hong Kong and United States. Wu-Ping Zheng's co-authors include Guang‐Hong Tan, Hengyu Chen, Shu-Zhen Dai, Feng‐Ying Huang, Yingying Lin, Hui Guo, Jin Hu, Haohao Huang, Zihan Xi and Liu Yang and has published in prestigious journals such as PLoS ONE, Biomaterials and Advanced Functional Materials.

In The Last Decade

Wu-Ping Zheng

24 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wu-Ping Zheng China	11	225	124	57	55	49	27	349
Yuchen Hou China	12	187 0.8×	102 0.8×	71 1.2×	33 0.6×	32 0.7×	21	311
Ruixin Wang China	13	249 1.1×	124 1.0×	58 1.0×	36 0.7×	54 1.1×	39	444
Hongfang Sun China	13	395 1.8×	128 1.0×	49 0.9×	32 0.6×	93 1.9×	32	535
Shuangshuang Lu China	12	143 0.6×	71 0.6×	46 0.8×	49 0.9×	133 2.7×	31	338
Francesca Maria Orlandella Italy	13	188 0.8×	141 1.1×	29 0.5×	29 0.5×	51 1.0×	26	317
Zixue Xuan China	12	233 1.0×	114 0.9×	60 1.1×	43 0.8×	107 2.2×	34	423
Xuyang Hou China	12	304 1.4×	140 1.1×	46 0.8×	40 0.7×	69 1.4×	22	410
Juntang Shao China	9	269 1.2×	127 1.0×	16 0.3×	44 0.8×	21 0.4×	13	371
Qing Mao China	6	278 1.2×	152 1.2×	20 0.4×	57 1.0×	39 0.8×	8	378

Countries citing papers authored by Wu-Ping Zheng

Since Specialization

Citations

This map shows the geographic impact of Wu-Ping Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu-Ping Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu-Ping Zheng more than expected).

Fields of papers citing papers by Wu-Ping Zheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu-Ping Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu-Ping Zheng. The network helps show where Wu-Ping Zheng may publish in the future.

Co-authorship network of co-authors of Wu-Ping Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wu-Ping Zheng. A scholar is included among the top collaborators of Wu-Ping Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu-Ping Zheng. Wu-Ping Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Shengping, Wenhui Xie, Minghui Chen, et al.. (2025). Toxicarioside H induces ferroptosis in triple-negative breast cancer cells through Nrf2/HO-1 pathway. Discover Oncology. 16(1). 772–772.

Hao, Lei, Jin Hu, Junpeng Zhu, et al.. (2025). Global research prospects and trends in TFH cells and tumors: a bibliometric analysis. Frontiers in Oncology. 15. 1443890–1443890.

Jiang, Jie, Hengyu Chen, Shu-Zhen Dai, et al.. (2025). Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens. Journal for ImmunoTherapy of Cancer. 13(2). e010150–e010150. 3 indexed citations

Xiong, Wei, Ziyi Cheng, Hongwei Chen, et al.. (2024). Biomimetic Tumor Cell Membrane‐Encapsulated Nanoparticles Combine NIR‐II Photothermal Therapy and Chemotherapy for Enhanced Immunotherapy in Triple‐Negative Breast Cancer. Advanced Functional Materials. 34(52). 36 indexed citations

Dai, Shu-Zhen, Hengyu Chen, Minghui Chen, et al.. (2024). Progesterone suppresses rhinovirus-induced airway inflammation by inhibiting neutrophil infiltration and extracellular traps formation. International Immunopharmacology. 144. 113714–113714. 2 indexed citations

Zhu, J., Feng‐Ying Huang, Hengyu Chen, et al.. (2024). Autocrine phosphatase PDP2 inhibits ferroptosis by dephosphorylating ACSL4 in the Luminal A Breast Cancer. PLoS ONE. 19(3). e0299571–e0299571. 2 indexed citations

Zhang, Xiaodian, Xiaomei Yang, Na He, et al.. (2024). A novel doxorubicin/CTLA-4 blocker co-loaded drug delivery system improves efficacy and safety in antitumor therapy. Cell Death and Disease. 15(6). 386–386. 13 indexed citations

Li, Ping, et al.. (2023). The global status and hotspots of research in the field of trans-oral endoscopic thyroidectomy (TOET) from 2008 to 2022. Frontiers in Surgery. 10. 1120442–1120442. 1 indexed citations

Wang, Yu, et al.. (2023). Top 100 cited classical articles in sentinel lymph nodes biopsy for breast cancer. Frontiers in Oncology. 13. 1170464–1170464.

10.

Zhang, Yun‐Long, Feng‐Ying Huang, Hengyu Chen, et al.. (2023). Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells. Scientific Reports. 13(1). 21916–21916. 31 indexed citations

11.

Bi, Xiaoman, Liyang Chen, Meng Cao, et al.. (2023). Pan‐cancer analyses reveal multi‐omic signatures and clinical implementations of the forkhead‐box gene family. Cancer Medicine. 12(16). 17428–17444. 3 indexed citations

12.

Chen, Hengyu, Ming Yang, Haohao Huang, et al.. (2022). YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner. Cell & Bioscience. 12(1). 19–19. 80 indexed citations

13.

Huang, Feng‐Ying, Shu-Zhen Dai, Wentian Xu, et al.. (2022). 3′-epi-12β-hydroxyfroside-mediated autophagy degradation of RIPK1/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells. Pharmacological Research. 187. 106613–106613. 23 indexed citations

14.

Hu, Jin, Haohao Huang, Zihan Xi, et al.. (2022). LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis. Cell Death and Disease. 13(9). 800–800. 35 indexed citations

15.

Zheng, Wu-Ping, Feng‐Ying Huang, Shu-Zhen Dai, et al.. (2021). Toxicarioside O Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition by Downregulation of Trop2 in Lung Cancer Cells. Frontiers in Oncology. 10. 609275–609275. 11 indexed citations

16.

Wang, Yu, et al.. (2021). Clinical analysis of endoscopic and open subcutaneous mastectomy in the treatment of early breast cancer. Minerva Surgery. 78(2). 221–223. 1 indexed citations

17.

Huang, Feng‐Ying, Shu-Zhen Dai, Jin‐Yan Wang, et al.. (2021). Engineered porous/hollow Burkholderia pseudomallei loading tumor lysate as a vaccine. Biomaterials. 278. 121141–121141. 17 indexed citations

18.

Zheng, Wu-Ping, et al.. (2018). Treatment efficacy between total thyroidectomy and lobectomy for patients with papillary thyroid microcarcinoma: A systemic review and meta-analysis. European Journal of Surgical Oncology. 44(11). 1679–1684. 24 indexed citations

19.

Zheng, Wu-Ping, et al.. (2013). Completely thoracoscopic right upper lobectomy and mediastinal lymph node dissection.. ASVIDE. 1(1). 1 indexed citations

20.

Zheng, Wu-Ping. (2010). Expression and clinical significance of YAP in breast carcinoma tissues. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact